Microbiome identification and bacteriophage formulations
US-2024123002-A1 · Apr 18, 2024 · US
US2016103128A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016103128-A1 |
| Application number | US-201514876007-A |
| Country | US |
| Kind code | A1 |
| Filing date | Oct 6, 2015 |
| Priority date | Oct 10, 2002 |
| Publication date | Apr 14, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides novel immunogenic proteins LigA and LigB from Leptospira for use in the development of effective vaccines and antibodies, as well as improved diagnostic methods and kits.
Opening claim text (preview).
1 - 24 . (canceled) 25 . A device comprising a solid surface, wherein at least one antibody is immobilized on the solid surface, wherein such antibody can specifically bind to a LigB protein from Leptospira interrogans , wherein the LigB protein is characterized in that it is a protein (i) comprising SEQ ID NO: 4, SEQ ID NO: 34, or SEQ ID NO: 46, or (ii) consisting of at least 9 contiguous amino acids of SEQ ID NO: 46. 26 . A device as claimed in cla…
Physics · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Physics · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.